BridgeBio Pharma, Inc. ($BBIO)
Scott Randal W. โ Director
Shares
10,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.74
Revenue:Est: $149.07M
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Scott Randal W. |
|---|---|
| Title | Director |
| Transaction Date | Feb 17, 2026 |
| Expiration Date | Jun 21, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Purchased | 10,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 31,501 |
| Derivative | Derivative |
| Accession Number | 0001470831-26-000182 |
| Document | View SEC Filing |